Since anti-obesity drugs such as semaglutide (branded as Ozempic or Wegovy) have been approved, they have gone from being niche medicines prescribed by doctors to treat people with type 2 diabetes, to being used widely as weight-loss tools. In the United States, a survey of adults found that 12%…